Roots Analysis

Roots Analysis provide business research and consulting in the pharmaceutical industry. Focussed on providing an informed and impartial view on key issues facing the industry, our research is primarily driven by an in-depth analysis covering the following parameters:

•Technology evolution
•Research and development
•Existing market landscape
•Future Commercial potential
•Regulatory concerns
•Regional growth drivers
•Risks and opportunities

Roots Analysis
 

List of reports from Roots Analysis

PCSK9 and Other Novel Hypercholesterolemia Drugs Market, 2014 - 2024
9/5/2014 | published by: Roots Analysis
... available options, statins have been ubiquitously prescribed over the last 25 years. Researchers have concluded that reduction of plasma LDL cholesterol (LDLC) is the cornerstone of assessing heart risk. Irrespective of baseline cholesterol concentration, each ...  |  read more...
USD 1,899
Glycated Haemoglobin (HbA1c) Testing Market, 2014 - 2024
8/14/2014 | published by: Roots Analysis
... the number, though, is likely to increase to 592 million by 2035. With a very high prevalence, especially in some regions such as China and India, an increasing proportion of diabetic patients are expected to ...  |  read more...
USD 1,899
HPAPIs and Cytotoxic Drugs Manufacturing Market, 2014 - 2024
8/6/2014 | published by: Roots Analysis
... The trend is likely to continue and the anti-cancer market will drive the growth of HPAPIs and cytotoxics in the future. 2. A good proportion of HPAPI / cytotoxics manufacturing is currently outsourced. In fact, ...  |  read more...
USD 1,899
Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024
8/4/2014 | published by: Roots Analysis
... more than USD 600 million in 2014. 2. About 45 molecules are currently in clinical development. Of these, approximately 25% are in Phase II or Phase III of development. As expected, the preclinical pipeline is ...  |  read more...
USD 1,899
Prefilled Syringes Market (2nd Edition), 2014 - 2024
7/15/2014 | published by: Roots Analysis
... 2024, we expect the market to achieve sales of around 12.4 billion prefilled syringes. 2. Vaccines, diluent and flush syringes are likely to be some of the key growth areas. The emergence of biologics will ...  |  read more...
USD 1,899
Pharmaceutical Spray Drying Market, 2014 - 2024
6/24/2014 | published by: Roots Analysis
... These include Intelence, Kalydeco, Incivek, and Zortress. 2. Specific to the pharmaceutical industry, there are around 50 models of spray dryers which are currently available worldwide. These models offer variation in the scale of operation ...  |  read more...
USD 1,899
Diagnostics: Companion Diagnostics Market (2nd Edition), 2014-2024
6/5/2014 | published by: Roots Analysis
... of companion diagnostics holds huge potential for pharma companies as well as medical community. This new approach to medication is expected to transform healthcare by improving treatment outcomes, eliminating adverse reactions and reducing cost and ...  |  read more...
USD 1,899
Oral Oncolytics Series: Leukemia, 2014-2024
5/21/2014 | published by: Roots Analysis
... to patients (especially pediatric and geriatric patients). In the case of leukemia, current marketed oral drugs include Gleevec, Tasigna, Sprycel, Bosulif, Imbruvica and Iclusig. The high price of these drugs still remains a major constraint ...  |  read more...
USD 1,899
Dry Eye Syndrome: Clinical Trial Tracker
4/29/2014 | published by: Roots Analysis
... no cure for dry eye syndrome, but there are treatments to control its symptoms. The prevalence of dry eye syndrome primarily increases with age, and has an estimated incidence of 15% in persons over the ...  |  read more...
USD 799
Single-use Bioreactors Market, 2014-2024
4/23/2014 | published by: Roots Analysis
... the use of vials and pipettes, has emerged rapidly over the last decade. Today, this term surrounds a wide range of primarily plastic disposable technologies that are suitable for a wide variety of scales, from ...  |  read more...
USD 1,899
Sustained Release Ocular Drug Delivery Systems Market, 2014-2024
4/8/2014 | published by: Roots Analysis
... Several barriers have to be overcome for successful ocular drug delivery. For example, dilution of a drug by tears, clearance of a drug by the lymphatic system of conjunctiva, drug permeation issues with respect to ...  |  read more...
USD 1,899
3D Bioprinting Market, 2014-2030
3/1/2014 | published by: Roots Analysis
... benefitted from multiple advancements in this field, resulting in improved and more efficient processes worldwide. A quick look at www.3dprintingchannel.com suggests that 3D printing has multi-faceted dimensions; the technology has recently been used in varied ...  |  read more...
USD 1,899
Bispecific Antibodies: Clinical Trial Tracker
2/13/2014 | published by: Roots Analysis
... different epitopes concurrently. Various technology platforms have been used for bsAbs production over the years. These platforms are based on the concepts of chemical crosslinking, hybrid hybridomas, with the latest being recombinant techniques. Different binding ...  |  read more...
USD 799
Antibody Drug Conjugates: Contract Manufacturing Market, 2014-2024
2/5/2014 | published by: Roots Analysis
... antibody. However, the practical challenge of manufacturing such complex and highly toxic molecules is huge. The multi-component aspect of ADCs deems it necessary to have both biologic and high-potency facilities. Despite the fact that this ...  |  read more...
USD 1,899
Oral Proteins and Peptides Market, 2014-2024
11/21/2013 | published by: Roots Analysis
... made some progress in other routes of delivery such as transdermal, intranasal, inhalation and oral administration. Amongst the various modes of administration, oral delivery is the most preferred route. Although very convenient, there are many ...  |  read more...
USD 1,699
Antibody Drug Conjugates: Clinical Trial Tracker
11/6/2013 | published by: Roots Analysis
... of an antibody with a toxic drug / chemotherapy drug, these conjugates are believed to be more efficient and effective in the treatment of a disease. The ADC market is still in its infancy. The ...  |  read more...
USD 799
Bolus Injectors Market, 2014-2024
11/1/2013 | published by: Roots Analysis
... auto-injectors, the market has come a long way. Taking the concept of self-injectors to a new stratum, ‘Bolus Injectors’ have surfaced recently. Also known as non-insulin patch pumps, these devices not only offer a range ...  |  read more...
USD 1,699
Bispecific Antibody Therapeutics Market, 2013-2023
9/24/2013 | published by: Roots Analysis
... anti-CD3 antibody, Orthoclone Okt3, in 1986. A bispecific antibody is a second generation immunotherapy, an upgraded version of monoclonal antibody improved in structure and functionality. The conjugated artificial antibodies are formed by physically putting together ...  |  read more...
USD 1,699
Fc Protein and Glycoengineered Antibodies Market, 2013 – 2023
9/4/2013 | published by: Roots Analysis
... is to develop antibodies with improved efficacy. Research done in the last decade to develop engineered antibodies has yielded a rich knowledge base on how to develop and market these next generation antibodies. These therapeutic ...  |  read more...
USD 1,699
Prefilled Syringes Market, 2013 - 2023
7/1/2013 | published by: Roots Analysis
... patients to self-administer medication several times a week. The rising demand for prefilled syringes is driving the manufacturers to introduce improvements in technology related to the material of prefilled syringes, and lubrication technology to reduce ...  |  read more...
USD 1,699
Antibody Drug Conjugates Market, 2012-2023
5/31/2013 | published by: Roots Analysis
... of drug developers, with several large and small companies entering the market through collaboration and licensing agreements with technology providers. The ADC market is still in its infancy. So far, three ADCs have received market ...  |  read more...
USD 1,699
Alzheimer's Drugs Market, 2012 - 2017
5/10/2013 | published by: Roots Analysis
... the future. There is a huge unmet need in the market owing to lack of effective, disease-modifying drugs. Alzheimer’s treatment is a high risk, high reward market. Drugs currently available in the market have reached ...  |  read more...
USD 1,699
Neurostimulation Devices Market, 2012 - 2017
5/3/2013 | published by: Roots Analysis
... mainly focus on spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS) and sacral nerve stimulation (SNS). The market is still niche, with limited number of devices available in the market. The ...  |  read more...
USD 1,699
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!